Printer Friendly Printer Friendly   | Text Size Decrease Text Size Increase Text Size

The Miracle of Sight — New Hope for the Blind

This is the final article in a five-part series of web features that explores the wonderment of eyesight, the care and keeping of eyes, common eye ailments and treatments, the future of eye care and the emerging hope for the blind.

Most of us can only imagine what it would be like to completely lose our vision, but for millions of people around the world, a slow fade into blindness is a sad reality. The top three causes of blindness do not steal vision overnight. Rather, vision loss is progressive, moving toward a debilitating loss and eventually, for many, into blindness. If you are living in a developed nation, you might be surprised to learn that the three diseases most likely to cause blindness in people around the world are cataracts, glaucoma and age-related macular degeneration (AMD) – all are typically treatable conditions.

Cataracts

In fact, there are 15 million cataract surgeries performed around the world each year. However, outside of the U.S., cataracts are the leading cause of blindness, and cases are expected to rise with the aging of the global population. Cataracts, a clouding of the lens of the eye, can be effectively treated through a surgical procedure where the cataract is removed and an intraocular lens is implanted. Some of the newest transplanted lenses are multi-focal or accommodating, allowing the patient to see well close up and at a distance. Much research is now underway to develop a next generation intraocular lens that will improve the overall vision for people who undergo cataract surgery.

Glaucoma

There are 62 million people around the world suspected of having glaucoma, yet it’s estimated some 75 percent are undiagnosed due to its insidious onset and slow progression, as well as limited access to health care. Glaucoma, a build-up of fluid pressure within the eye, is treated by reducing intraocular pressure using a progression of methods – starting with topical drops and climaxing with surgical placement of a shunt – because the response to drug therapy typically declines over time. A number of companies are working at improving existing devices that lower intraocular pressure, including shunts. If the safety, reliability and efficacy of shunts are improved, this device might be used earlier in the disease to halt its progression.

Age-related macular degeneration

Approximately 133 million people around the world have AMD and it is the leading cause of vision loss in people over 60. One form of AMD is caused by improper blood vessel growth in the macula, the small central part of the retina. Treating AMD begins with diet and lifestyle changes. Historically, the next step has been laser surgery. The latest treatment involves drugs that block VEGF (vascular endothelial growth factor), the growth factor necessary to create new blood vessels. Thus, blocking VEGF addresses a principal cause of AMD. Now under development by a number of companies are anti-angiogenic and anti-inflammatory compounds that stop the growth of new blood vessels. At least one company is exploring the use of radiation therapy to treat AMD.

More on the horizon

There is great hope for people with retinal diseases, including retinitis pigmentosa, agenetic eye disease that causes progressive loss of vision. Progress is real, and includes early work on stem cell and retina transplants, as well as electrical retinal transplants. The challenge for researchers is to get a signal to the brain that it can process. Initially at least, patients who undergo these treatments may see patterns of light and dark that comprise a basic level of vision.

The bionic eye is also under development. Some patients have already received bionic eye transplants, where electronic receivers are implanted in the eye that take signals from a camera mounted in a pair of glasses. The electrodes stimulate the remaining retinal nerves, creating a pathway for a signal to be passed along the optic nerve to the brain. This technology may not fully restore vision, but the hope is that it will allow the patient to see light and dark patterns, enough to find doorways, follow someone else and help with eating.

Additional "Miracle of Sight" Features

More Features